Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel R Denmeade

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2021
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen TherapyMark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.
Annals of Nuclear Medicine|June 1, 2019
Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted <sup>18</sup>F-DCFPyL PET/CTAlexa R Meyer, Michael A Carducci, Samuel R Denmeade, et al.
American Journal of Clinical Oncology|August 8, 2006
Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinomaVictoria J Sinibaldi, Kathy Elza-Brown, Jill Schmidt, et al.
JAMA Oncology|July 17, 2015
Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate CancerEmmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.
The Prostate|June 25, 2016
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN StudyMichael T Schweizer, Hao Wang, Brandon Luber, et al.
The Prostate|July 31, 2019
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancerChanning J Paller, Danilo Piana, James R Eshleman, et al.
Oncotarget|May 12, 2017
Mesenchymal stem cell infiltration during neoplastic transformation of the human prostateW Nathaniel Brennen, Baohui Zhang, Ibrahim Kulac, et al.
The Prostate|April 20, 2024
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancerCatherine H Marshall, Lukasz P Gondek, Violet Daniels, et al.
The Prostate|April 8, 2026
Castration Resistance Accelerates Prostate Cancer KineticsSheila Jonnatan, Luka Cavka, Angelo M De Marzo, et al.
The Prostate|January 3, 2025
Nectin-4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical StudyEzra G Baraban, Evangelia Vlachou, Sunil Patel, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2021
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen TherapyMark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.
Annals of Nuclear Medicine|June 1, 2019
Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted <sup>18</sup>F-DCFPyL PET/CTAlexa R Meyer, Michael A Carducci, Samuel R Denmeade, et al.
American Journal of Clinical Oncology|August 8, 2006
Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinomaVictoria J Sinibaldi, Kathy Elza-Brown, Jill Schmidt, et al.
JAMA Oncology|July 17, 2015
Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate CancerEmmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.
The Prostate|June 25, 2016
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN StudyMichael T Schweizer, Hao Wang, Brandon Luber, et al.
The Prostate|July 31, 2019
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancerChanning J Paller, Danilo Piana, James R Eshleman, et al.
Oncotarget|May 12, 2017
Mesenchymal stem cell infiltration during neoplastic transformation of the human prostateW Nathaniel Brennen, Baohui Zhang, Ibrahim Kulac, et al.
The Prostate|April 20, 2024
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancerCatherine H Marshall, Lukasz P Gondek, Violet Daniels, et al.
The Prostate|April 8, 2026
Castration Resistance Accelerates Prostate Cancer KineticsSheila Jonnatan, Luka Cavka, Angelo M De Marzo, et al.
The Prostate|January 3, 2025
Nectin-4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical StudyEzra G Baraban, Evangelia Vlachou, Sunil Patel, et al.
Pageof 16